OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
5
Results
Show all
Save search
Copy query
Show results for
Unknown
(4)
Proteomics
(1)
Organisms
Alphavirus
(1)
Betaherpesvirinae
(1)
Brassica oleracea var. oleracea
(1)
Cowpox virus
(1)
Coxsackievirus
(1)
Cytomegalovirus
(1)
Dengue virus
(1)
EFO:0001352
(1)
Filoviridae
(1)
Hepatitis B virus
(1)
Human alphaherpesvirus 1
(1)
Human betaherpesvirus 5
(1)
Human immunodeficiency virus
(1)
Human immunodeficiency virus 1
(1)
Human immunodeficiency virus 2
(1)
Influenza A virus
(1)
Influenza C virus
(1)
Japanese encephalitis virus
(1)
Japanese encephalitis virus group
(1)
Lyssavirus rabies
(1)
Monkeypox virus
(1)
Nostoc sp. PCC 7120 = FACHB-418
(1)
Oropouche virus
(1)
Orthopoxvirus
(1)
Orthopoxvirus vaccinia
(1)
Rattus
(1)
Staphylococcus aureus
(1)
Tick-borne encephalitis virus
(1)
Viruses
(1)
West Nile virus
(1)
Repository
pride
(1)
Technology Type
Gel-based experiment
(1)
Mass Spectrometry
(1)
Publication Date
2025
(1)
Release Date
2025
(2)
2023
(1)
2021
(1)
Lab affiliation
1. School of Biological Sciences, National Institute of Science Education and Research, Bhubaneswar – 752050, India 2. Homi Bhabha National Institutes (HBNI), Training School Complex, Anushakti Nagar, Mumbai, India 400094
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Mass Spectrometry of Escherichia coli expressing ParA from F' plasmid or weak IPTG inducible promoter (pDSW210 vector)
Comparisonof ParA levels in E. coli carrying mini-F plasmids (ParA expressed from the native ParA promoter) with ParA-GFP levels expressed froma weak Ptrc promoter in pDSW210 vector.
ORGANISM(S):
Escherichia coli
2025-07-07
|
PXD064422
|
Pride
F' plasmid
Escherichia coli
Para
Cite
Developmental trends in early childhood and their predictors from an Indian birth cohort.
Not available
S-EPMC8180095
|
biostudies-literature
Cite
Burden of Typhoid and Paratyphoid Fever in India.
Not available
S-EPMC10116367
|
biostudies-literature
Cite
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.
Not available
S-EPMC12303861
|
biostudies-literature
Cite
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.
Not available
S-EPMC11869088
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets